ACT for PD: The Calgary Movement Disorders Advanced Care Pilot Program

Sponsor
University of Calgary (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05599659
Collaborator
(none)
100
1
1
24
4.2

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to analyse the effect of palliative care interventions on quality of life, patient satisfaction, carepartner burden and health care utilization patterns in patients living with parkisonism and their carepartners.

Participants will:
  • Receive multidisciplinary palliative care.

  • Answer questions related to the quality of life, patient satisfaction, carepartner burden and health care utilization patterns.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Palliative care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
The clinical trial is a prospective cohort study analysing the effect of palliative care interventions on quality of life, patient satisfaction, carepartner burden and health care utilization patterns in patients living with parkisonism and their carepartners. Participants will: Receive multidisciplinary palliative care. Answer questions related to the quality of life, patient satisfaction, carepartner burden and health care utilization patterns.The clinical trial is a prospective cohort study analysing the effect of palliative care interventions on quality of life, patient satisfaction, carepartner burden and health care utilization patterns in patients living with parkisonism and their carepartners.Participants will:Receive multidisciplinary palliative care. Answer questions related to the quality of life, patient satisfaction, carepartner burden and health care utilization patterns.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Calgary Movement Disorders Advanced Care Pilot Program
Anticipated Study Start Date :
Nov 4, 2022
Anticipated Primary Completion Date :
Nov 4, 2024
Anticipated Study Completion Date :
Nov 4, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Palliative care

Participants will receive palliative care.

Behavioral: Palliative care
It is a pilot model of outpatient clinical care for patients in advanced stages of PDRD that will allow earlier access to PC in this population. PC visits will be in person or by telemedicine every three months and complemented with phone calls by different team members when needed as defined by the PC team. The typical visit duration will be 2 to 2.5 hours and address nonmotor symptoms, goals of care, anticipatory guidance, difficult emotions, and carepartner support. Providers will communicate in-person or via notes during the clinic visit to increase interdisciplinary coordination and meet at the end of the day for discussion including follow-up plans. The team will consist of a neurologist, a registered nurse with palliative care experience and training, a psychology counselor, a social worker, spiritual counselor and a research assistant.
Other Names:
  • Advanced care
  • Outcome Measures

    Primary Outcome Measures

    1. Changes in Quality of Life Alzheimer's Disease (QOL-AD) [Every 3 months for 2 years]

      The QOL-AD is a 13-item questionnaire designed to provide both a patient and a caregiver report of the quality of life (QOL), it uses a scale of 1-4 (poor, fair, good, or excellent) to rate a variety of life domains, including the patient's physical health, mood, relationships, activities, and ability to complete tasks.

    2. Changes in 12-Item Zarit Burden Interview (ZBI-12) [Every 3 months for 2 years]

      ZBI-12 is validated as a screening tool for advanced illness. The ZBI-12 is rated on a 12 items scale, with the severity of burden using a range of responses from 0 to 4 points per item and a total score range of 0 to 48. Scoring 0-10 is considered as a no to mild burden; 10-20, a mild to moderate burden and >20, a high burden. It measures changes in physical, emotional, social, and financial problems that can be experienced by family caregivers.

    3. Changes in Health Care Utilization survey [Every 3 months for 2 years]

      We will perform a Health Service Utilization Survey to measure changes in the number of hospitalizations, emergency room visits, home health services, and nursing home placement.

    Secondary Outcome Measures

    1. Changes in Edmonton Symptom Assessment Scale revised for Parkinson's Disease (ESAS-PD) [Every 3 months for 2 years]

      The ESAS is a comprehensive, yet brief and practical self-reporting tool of symptom severity (intensity) for nine common symptoms of advanced cancer (pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, shortness of breath), with the option of adding a tenth patient-specific symptom. It rates the severity of each symptom on a 0 to 10 scale, where 0 represents the absence (or best possible intensity) of the symptom and 10 represents the worst possible severity.

    2. Changes in the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being (FACIT- Sp-12) [Every 3 months for 2 years]

      The 12-item Spiritual Well-Being Scale (FACIT-Sp-12) is the most widely used measure of spiritual well-being among those with long-term illness. The FACIT-Sp comprises 12 statements, or items, each of which is rated on a 5-point scale by the respondent based on how true the item was during the past week, 0 for not at all, 1 for a little bit, 2 for somewhat, 3 for quite a bit and 5 for very much.

    3. Semi-structured Qualitative Interview to receive Patient and Care Partner recommendations [Every 3 months for 2 years]

      It will be performed on patients and care partners for optimizing the palliative care services provided and delivery methods.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Participants who have a PD diagnosis or another PDRD diagnosis (multiple system atrophy, corticobasal degeneration, progressive supranuclear palsy, or Lewy body dementia)

    • Participants who have moderate to high PC needs based on the Palliative Care Needs Assessment Tool (PC-NAT)

    • Participants who are between 20 and 100 years old

    Exclusion Criteria:
    • Immediate and urgent palliative care needs. These patients will be offered appropriate services immediately

    • Participants who have other illnesses that could require PC e.g. metastatic cancer

    • Participants already receiving PC and/or hospice

    • Patients with a diagnosis of severe cognitive impairment (Montreal Cognitive Assessment <10). These patients will be offered appropriate services. Care partners can participate.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Movement Disorder Program, Foothills Medical Center, Alberta Health Services Calgary Alberta Canada T2N 4N1

    Sponsors and Collaborators

    • University of Calgary

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Veronica Bruno, MD, MPH, University of Calgary
    ClinicalTrials.gov Identifier:
    NCT05599659
    Other Study ID Numbers:
    • REB22-0545
    First Posted:
    Oct 31, 2022
    Last Update Posted:
    Oct 31, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Veronica Bruno, MD, MPH, University of Calgary
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 31, 2022